NFLX
36
-7
L
69
-2
ZION
61
4
NAVI
36
9
MA
48
2
PFE
50
2
THC
60
-4
PSA
56
5
DTE
43
3
BXP
46
-3
KMI
57
4
HP
48
2
UPS
40
2
NTAP
65
-2
MCHP
55
6
BEN
49
13
MDLZ
26
-16
DHI
47
6
EQR
50
-3
CME
49
-3
NFLX
36
-7
L
69
-2
ZION
61
4
NAVI
36
9
MA
48
2
PFE
50
2
THC
60
-4
PSA
56
5
DTE
43
3
BXP
46
-3
KMI
57
4
HP
48
2
UPS
40
2
NTAP
65
-2
MCHP
55
6
BEN
49
13
MDLZ
26
-16
DHI
47
6
EQR
50
-3
CME
49
-3
Financhill
Back

Dyne Therapeutics, Inc. 10K Form

Buy
64

DYN
Dyne Therapeutics, Inc.

Last Price:
$20.64
Seasonality Move:
4.74%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive DYN News And Ratings

See the #1 stock for the next 7 days that we like better than DYN

DYN Financial Statistics

Sales & Book Value

Annual Sales: $0
Cash Flow: $-110M
Price / Cash Flow: 0
Annual Sales: $4.85
Price / Book: 4.15

Profitability

EPS (TTM): -3.66010
Net Income (TTM): $-423.8M
Gross Margin: $-2.2M
Return on Equity: -64.85%
Return on Assets: -56.1%

Dyne Therapeutics, Inc. Earnings Forecast

Key Dyne Therapeutics, Inc. Financial Ratios

  • Per Share Earnings over the last 20 years have been positive in 9 years.

Dyne Therapeutics, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: DYN
CUSIP: 26818M
Website: dyne-tx.com

Debt

Debt-to-Equity Ratio: 0.17
Current Ratio: 13.47
Quick Ratio: 13.23

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

DYN Technical Analysis vs Fundamental Analysis

Buy
64
Dyne Therapeutics, Inc. (DYN) is a Buy

Is Dyne Therapeutics, Inc. a Buy or a Sell?